CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
28 hedge funds and large institutions have $4.23M invested in CASI Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$83K | |
| 2 | +$47.6K | |
| 3 | +$28.2K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$14.3K |
| 5 |
Renaissance Technologies
New York
|
+$7.82K |
Top Sellers
| 1 | -$22K | |
| 2 | -$19K | |
| 3 | -$18.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.06K |
| 5 |
BlackRock
New York
|
-$3.64K |